complete molecular response
Showing 1 - 1 of 1
Chronic Myeloid Leukemia, Imatinib, Complete Molecular Response Trial in Seoul (Imatinib treatment discontinuing)
Unknown status
- Chronic Myeloid Leukemia
- +2 more
- Imatinib treatment discontinuing
-
Seoul, Korea, Republic of
- +1 more
Jan 10, 2014